Study of a prospective cohort of health professionals with coronavirus infection (COVID-19) treated with hydroxychloroquine (VDH-HID-2020-02)

Study identification

• EU PAS number:
  EUPAS34570
• Study ID:
  34571
• Official title and acronym:
  Study of a prospective cohort of health professionals with coronavirus infection (COVID-19) treated with hydroxychloroquine (VDH-HID-2020-02)
• DARWIN EU® study:
  No
• Study countries:
  Spain
• Study description:
  Prospective, non-randomized, single-centered and controlled study that evaluates whether treatment with hydroxychloroquine in COVID-19 infected health personnel (PCRpositive) reduces the time of PCR negativization and therefore the contagiousness of the disease and the duration of symptoms.
• Study status:
  Planned

Research institutions and networks

Institutions

University Hospital Vall d’Hebron (HUVH)

Spain

Study timelines

Date when funding contract was signed

Planned:31/03/2020

Study start date

Planned:01/04/2020

Data analysis start date

Planned:30/04/2020

Date of final study report

Planned:27/05/2020

Sources of funding

Other

More details on funding

Institut Catala de Salut (ICS)

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable